ProGnosis Biotech is rated 3 out of 5 in the category biotechnology. Read and write reviews about ProGnosis Biotech. ProGnosis Biotech is an innovative Biotechnology Company, specialized in developing and manufacturing next-generation immuno-assays for the food/feed & clinical diagnostics industries. Based in Larissa, Greece, and having also offices in Thessaloniki, Madrid, and Beijing, ProGnosis Biotech is an export-oriented enterprise which through a large network of distributors, exports ELISA kits and Lateral-flow tests to more than 40 countries worldwide. In order to consistently provide top-quality products, our company participates on a monthly basis in Proficiency Tests in the UK, France, Germany, Italy, and the US. Additionally, ProGnosis Biotech offers validated products from the most highly esteemed organizations worldwide, and all the R&D and production procedures are certified with ISO 9001. Our mission is to provide innovative, accurate and simple solutions to the challenges presented in the food safety & clinical diagnostics industries. Our vision is to achieve a leading role in the diagnostics field by promoting consumers’ wellbeing based on high-quality standards "Accuracy through Innovation" is ProGnosis’s polestar achieved by producing swift reliable and innovative immunochemical tests.
Company size
11-50 employees
Headquarters
Larissa, Thessaly